Covid-19 Vaccine Janssen | License Info | Janssen Sciences Ireland

Company:
Janssen Sciences Ireland
Status:
Updated
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EUEU/1/20/1525/001

Adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein* (Ad26.COV2-S), not less than 8.92 log10 infectious units (Inf.U).

J07BX03

Suspension for injection

EUEU/1/20/1525/002

Adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein* (Ad26.COV2-S), not less than 8.92 log10 infectious units (Inf.U).

J07BX03

Suspension for injection

Covid-19 Vaccine Janssen *